Lmr Partners LLP Voyager Therapeutics, Inc. Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $114,288 - $205,337	19,048 New	19,048 $146,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $40,140 - $84,029	8,328 Added 33.66%	33,068 $195,000
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $68,035 - $233,545	24,740 New	24,740 $189,000
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $44,757 - $70,114	-17,018 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.94 - $5.44 $67,050 - $92,577	17,018 New	17,018 $70,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.